Target intelligence / Profile preview

MicroRNA 5590 (miR-5590)

Target
miR-5590
Molecular classification
MicroRNA, Non-coding RNA
01

Overview

MicroRNA 5590 (miR-5590) is a small, endogenous, non-coding RNA molecule that functions primarily as a post-transcriptional regulator of gene expression. Like other microRNAs, it binds to complementary sites in the 3' untranslated regions (UTRs) of target mRNAs, leading either to inhibition of translation or mRNA degradation. Specifically, miR-5590-3p has been identified as a tumor suppressor in ovarian cancer, where it downregulates the expression of Traf2 and Nck-interacting kinase (TNIK), thereby inhibiting the Wnt/β-catenin pathway relevant to tumor cell growth and invasion. Its expression profile and regulatory function suggest potential as both a biomarker for disease and a possible therapeutic target in oncology, particularly in cancers showing reduced miR-5590 levels.

Other names
hsa-mir-5590MIR5590miR-5590-3phsa-miR-5590
02

Mechanism of action

Transcriptional suppression of target mRNAs (such as TNIK) and modulation of Wnt/β-catenin signaling by inhibiting its pathway via suppression of TNIK expression.

03

Biological functions

Gene expression regulationPost-transcriptional gene silencingInhibition of mRNA through seed sequence bindingControl of cell proliferation, invasion, and differentiation
04

Disease associations

Cancer (including ovarian cancer, other malignancies)
05

Biomarkers

Potential biomarker for ovarian cancer progression

Beyond the preview

Go deeper on MicroRNA 5590 (miR-5590).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 5590 (miR-5590).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call